MONDELEZ INTERNATIONAL INC-A (MDLZ)

US6092071058 - Common Stock

59.39  +0.12 (+0.2%)

After market: 59.39 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MDLZ. MDLZ was compared to 91 industry peers in the Food Products industry. While MDLZ belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. MDLZ is not valued too expensively and it also shows a decent growth rate.



7

1. Profitability

1.1 Basic Checks

MDLZ had positive earnings in the past year.
In the past year MDLZ had a positive cash flow from operations.
MDLZ had positive earnings in each of the past 5 years.
MDLZ had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

With a decent Return On Assets value of 5.29%, MDLZ is doing good in the industry, outperforming 66.67% of the companies in the same industry.
MDLZ has a Return On Equity of 13.70%. This is in the better half of the industry: MDLZ outperforms 71.11% of its industry peers.
With a decent Return On Invested Capital value of 8.68%, MDLZ is doing good in the industry, outperforming 78.89% of the companies in the same industry.
MDLZ had an Average Return On Invested Capital over the past 3 years of 6.55%. This is below the industry average of 8.82%.
The last Return On Invested Capital (8.68%) for MDLZ is above the 3 year average (6.55%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.29%
ROE 13.7%
ROIC 8.68%
ROA(3y)5.72%
ROA(5y)5.7%
ROE(3y)14.27%
ROE(5y)14.03%
ROIC(3y)6.55%
ROIC(5y)6.31%

1.3 Margins

MDLZ has a Profit Margin of 10.56%. This is amongst the best in the industry. MDLZ outperforms 86.67% of its industry peers.
MDLZ's Profit Margin has been stable in the last couple of years.
The Operating Margin of MDLZ (17.18%) is better than 91.11% of its industry peers.
In the last couple of years the Operating Margin of MDLZ has remained more or less at the same level.
With an excellent Gross Margin value of 38.77%, MDLZ belongs to the best of the industry, outperforming 91.11% of the companies in the same industry.
MDLZ's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 17.18%
PM (TTM) 10.56%
GM 38.77%
OM growth 3Y0.4%
OM growth 5Y0.42%
PM growth 3Y0.97%
PM growth 5Y1.49%
GM growth 3Y-0.93%
GM growth 5Y-0.86%

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), MDLZ is creating some value.
Compared to 1 year ago, MDLZ has less shares outstanding
The number of shares outstanding for MDLZ has been reduced compared to 5 years ago.
MDLZ has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.41 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
MDLZ's Altman-Z score of 2.41 is in line compared to the rest of the industry. MDLZ outperforms 52.22% of its industry peers.
The Debt to FCF ratio of MDLZ is 5.35, which is a neutral value as it means it would take MDLZ, 5.35 years of fcf income to pay off all of its debts.
MDLZ has a better Debt to FCF ratio (5.35) than 65.56% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that MDLZ is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.65, MDLZ is in line with its industry, outperforming 42.22% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.35
Altman-Z 2.41
ROIC/WACC1.13
WACC7.69%

2.3 Liquidity

A Current Ratio of 0.63 indicates that MDLZ may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.63, MDLZ is doing worse than 84.44% of the companies in the same industry.
MDLZ has a Quick Ratio of 0.63. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.42, MDLZ is not doing good in the industry: 81.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.63
Quick Ratio 0.42

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.75% over the past year.
The Earnings Per Share has been growing slightly by 6.38% on average over the past years.
MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 2.13%.
The Revenue has been growing slightly by 6.79% on average over the past years.
EPS 1Y (TTM)13.75%
EPS 3Y8.1%
EPS 5Y6.38%
EPS Q2Q%20.73%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y10.66%
Revenue growth 5Y6.79%
Sales Q2Q%1.94%

3.2 Future

The Earnings Per Share is expected to grow by 5.87% on average over the next years.
Based on estimates for the next years, MDLZ will show a small growth in Revenue. The Revenue will grow by 4.00% on average per year.
EPS Next Y7.5%
EPS Next 2Y2.44%
EPS Next 3Y5.59%
EPS Next 5Y5.87%
Revenue Next Year1.63%
Revenue Next 2Y2.92%
Revenue Next 3Y3.36%
Revenue Next 5Y4%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.32 indicates a correct valuation of MDLZ.
Compared to the rest of the industry, the Price/Earnings ratio of MDLZ indicates a somewhat cheap valuation: MDLZ is cheaper than 71.11% of the companies listed in the same industry.
MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.20.
Based on the Price/Forward Earnings ratio of 17.10, the valuation of MDLZ can be described as rather expensive.
MDLZ's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MDLZ is cheaper than 72.22% of the companies in the same industry.
MDLZ is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.73, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 16.32
Fwd PE 17.1

4.2 Price Multiples

MDLZ's Enterprise Value to EBITDA is on the same level as the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as MDLZ.
Industry RankSector Rank
P/FCF 21.46
EV/EBITDA 12.84

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of MDLZ may justify a higher PE ratio.
PEG (NY)2.18
PEG (5Y)2.56
EPS Next 2Y2.44%
EPS Next 3Y5.59%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.17%, MDLZ has a reasonable but not impressive dividend return.
The stock price of MDLZ dropped by -20.05% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.83, MDLZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, MDLZ pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.17%

5.2 History

The dividend of MDLZ is nicely growing with an annual growth rate of 11.47%!
MDLZ has paid a dividend for at least 10 years, which is a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.47%
Div Incr Years10
Div Non Decr Years10

5.3 Sustainability

MDLZ pays out 60.30% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP60.3%
EPS Next 2Y2.44%
EPS Next 3Y5.59%

MONDELEZ INTERNATIONAL INC-A

NASDAQ:MDLZ (12/20/2024, 8:23:54 PM)

After market: 59.39 0 (0%)

59.39

+0.12 (+0.2%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)10-29 2024-10-29/amc
Earnings (Next)01-28 2025-01-28/amc
Inst Owners83.81%
Inst Owner Change0.38%
Ins Owners0.14%
Ins Owner Change0.14%
Market Cap79.42B
Analysts81.82
Price Target81.69 (37.55%)
Short Float %0.85%
Short Ratio1.59
Dividend
Industry RankSector Rank
Dividend Yield 3.17%
Dividend Growth(5Y)11.47%
DP60.3%
Div Incr Years10
Div Non Decr Years10
Ex-Date12-31 2024-12-31 (0.47)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.63%
Min EPS beat(2)6.99%
Max EPS beat(2)14.26%
EPS beat(4)4
Avg EPS beat(4)8.06%
Min EPS beat(4)5.03%
Max EPS beat(4)14.26%
EPS beat(8)8
Avg EPS beat(8)6.74%
EPS beat(12)11
Avg EPS beat(12)5.89%
EPS beat(16)12
Avg EPS beat(16)4.79%
Revenue beat(2)0
Avg Revenue beat(2)-2.12%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)-0.99%
Revenue beat(4)0
Avg Revenue beat(4)-1.69%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)-0.6%
Revenue beat(8)4
Avg Revenue beat(8)0.42%
Revenue beat(12)7
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)0.97%
PT rev (1m)-0.5%
PT rev (3m)2.09%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.09%
EPS NY rev (1m)-0.05%
EPS NY rev (3m)-0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.57%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)0.12%
Valuation
Industry RankSector Rank
PE 16.32
Fwd PE 17.1
P/S 2.2
P/FCF 21.46
P/OCF 15.84
P/B 2.85
P/tB N/A
EV/EBITDA 12.84
EPS(TTM)3.64
EY6.13%
EPS(NY)3.47
Fwd EY5.85%
FCF(TTM)2.77
FCFY4.66%
OCF(TTM)3.75
OCFY6.31%
SpS27.04
BVpS20.83
TBVpS-11.5
PEG (NY)2.18
PEG (5Y)2.56
Profitability
Industry RankSector Rank
ROA 5.29%
ROE 13.7%
ROCE 12.15%
ROIC 8.68%
ROICexc 8.94%
ROICexgc 58.15%
OM 17.18%
PM (TTM) 10.56%
GM 38.77%
FCFM 10.24%
ROA(3y)5.72%
ROA(5y)5.7%
ROE(3y)14.27%
ROE(5y)14.03%
ROIC(3y)6.55%
ROIC(5y)6.31%
ROICexc(3y)6.86%
ROICexc(5y)6.61%
ROICexgc(3y)39.94%
ROICexgc(5y)36.4%
ROCE(3y)9.04%
ROCE(5y)8.75%
ROICexcg growth 3Y17.96%
ROICexcg growth 5Y12.82%
ROICexc growth 3Y9.68%
ROICexc growth 5Y5.98%
OM growth 3Y0.4%
OM growth 5Y0.42%
PM growth 3Y0.97%
PM growth 5Y1.49%
GM growth 3Y-0.93%
GM growth 5Y-0.86%
F-Score8
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 5.35
Debt/EBITDA 2.4
Cap/Depr 102.34%
Cap/Sales 3.63%
Interest Coverage 250
Cash Conversion 66.92%
Profit Quality 96.99%
Current Ratio 0.63
Quick Ratio 0.42
Altman-Z 2.41
F-Score8
WACC7.69%
ROIC/WACC1.13
Cap/Depr(3y)86.69%
Cap/Depr(5y)85.15%
Cap/Sales(3y)3.11%
Cap/Sales(5y)3.23%
Profit Quality(3y)85.66%
Profit Quality(5y)84.32%
High Growth Momentum
Growth
EPS 1Y (TTM)13.75%
EPS 3Y8.1%
EPS 5Y6.38%
EPS Q2Q%20.73%
EPS Next Y7.5%
EPS Next 2Y2.44%
EPS Next 3Y5.59%
EPS Next 5Y5.87%
Revenue 1Y (TTM)2.13%
Revenue growth 3Y10.66%
Revenue growth 5Y6.79%
Sales Q2Q%1.94%
Revenue Next Year1.63%
Revenue Next 2Y2.92%
Revenue Next 3Y3.36%
Revenue Next 5Y4%
EBIT growth 1Y14.62%
EBIT growth 3Y11.1%
EBIT growth 5Y7.23%
EBIT Next Year28.25%
EBIT Next 3Y11.38%
EBIT Next 5Y9.13%
FCF growth 1Y23.78%
FCF growth 3Y5.12%
FCF growth 5Y4.77%
OCF growth 1Y27.38%
OCF growth 3Y5.95%
OCF growth 5Y3.61%